Medpace Holdings (MEDP) Net Cash Flow (2015 - 2026)

Medpace Holdings (MEDP) has reported Net Cash Flow for 12 consecutive years, with $157.7 million the latest figure, recorded in Q1 2026.

• Net Cash Flow for Q1 2026 came in at $157.7 million, up 168.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $209.5 million (up 525.18% YoY), and the FY2025 annual result was -$178.3 million, down 141.81% from the prior year.
• Net Cash Flow was $157.7 million for Q1 2026 at Medpace Holdings, down from $210.9 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $239.0 million in Q3 2025 and troughed at -$398.1 million in Q2 2025.
• Average Net Cash Flow over 5 years is $11.5 million, with a median of $17.9 million recorded in 2023.
• Year-over-year, Net Cash Flow tumbled 764.14% in 2022 and surged 4199.56% in 2023.
• Over 5 years, Net Cash Flow stood at -$3.7 million in 2022, then soared by 4199.56% to $149.9 million in 2023, then plunged by 90.33% to $14.5 million in 2024, then jumped by 1355.04% to $210.9 million in 2025, then declined by 25.22% to $157.7 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $157.7 million in Q1 2026, $210.9 million in Q4 2025, and $239.0 million in Q3 2025.